Please login to the form below

Not currently logged in
Email:
Password:

ulipristal acetate

This page shows the latest ulipristal acetate news and features for those working in and with pharma, biotech and healthcare.

MHRA suspends new prescriptions of fibroid drug Esmya

MHRA suspends new prescriptions of fibroid drug Esmya

Esmya (ulipristal acetate) is a selective progesterone receptor modulator billed as a safer and more effective pharmacological treatment for uterine fibroids than existing drugs such as AbbVie's Lupron (leuprolide acetate),

Latest news

More from news
Approximately 1 fully matching, plus 9 partially matching documents found.

Latest Intelligence

  • The pill branding The pill branding

    In the UK, Levonelle with the active ingredient levonorgestrel and ellaOne containing ulipristal acetate are sold over the counter to girls over 16 since 2001. ... the binding landmark decision of switching the ellaOne (ulipristal acetate) pill to an OTC

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
CSafe Global

CSafe Global is the only global provider of a full line of cold chain solutions and is the world’s largest...

Latest intelligence

Island
Pharma’s isolated islands of innovation
With service design and technology often failing the patient, why perspective on improving outcomes need to change...
Uncertainty, austerity and Brexit
What does it mean for the life science sector?...
The Holy Grail of HCP Access
This is the data you need to gain access....

Infographics